MedTrace Logo

Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)

NCT04041167 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-08-02

No results posted yet for this study

Summary

This study aims to investigate the effectiveness and safety of alpha-lipoic acid in patients with diabetes and ischemic stroke treated with reperfusion therapy.

Conditions

  • Stroke, Ischemic

Interventions

DRUG

alpha lipoic acid

alpha lipoic acid treatment

DRUG

Saline

No alpha lipoic acid treatment

Sponsors & Collaborators

  • Chosun University Hospital

    collaborator OTHER

  • Chonbuk National University Hospital

    collaborator OTHER

  • Wonkwang University Hospital

    collaborator OTHER

  • Chonnam National University Hospital

    lead OTHER

Principal Investigators

  • Kangho Choi, MD, PhD · Chonnam National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2021-07-31
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04041167 on ClinicalTrials.gov